← Open Payments lookup

WAFAA FARAG: Open Payments

NPI 1205894920 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,595 in 46 payments from 11 companies in 2025. Trend: 2023 $665 · 2024 $1,015 · 2025 $1,595

Food & beverage: $1,595
CompanyPaymentsAmount
Alkermes, Inc.6$317
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$309
Indivior Inc.6$269
ABBVIE INC.12$254
Otsuka America Pharmaceutical, Inc.4$105
Axsome Therapeutics, Inc.1$104
Braeburn Inc.4$91
Almatica Pharma LLC2$56
Neurocrine BioSciences, Inc.2$45
Lundbeck LLC1$25

Products named: CAPLYTA, SUBLOCADE, VRAYLAR, ARISTADA, LYBALVI, REXULTI, Auvelity, BRIXADI.

Industry payments across TX — which companies pay providers there.